Citation: | ZHANG Qiuyue, YOU Qidong, YANG Jinpeng. Process improvement on the synthesis of atomoxetine[J]. Journal of China Pharmaceutical University, 2019, 50(4): 405-409. DOI: 10.11665/j.issn.1000-5048.20190404 |
[1] |
Du YS.New drug for the treatment of ADHD-tomoxetine [J].Chin J Child Health Care(中国儿童保健杂志),2008,16(1):65-69.
|
[2] |
Li H.Improvement of the efficacy of atomoxetine in children with dysmotility and attention deficit hyperactivity disorder[J].Maternal Child Health Care Chin(中国妇幼保健),2018,33(22):5165-5167.
|
[3] |
Molly BB, Schmiegel KK. Arolxyphenylpropylamines: US,4314081[P].1982-02-02[2019-02-27] .
|
[4] |
Ashok K,Dilip HN,Suneel Y.A new chemoenzymatic enantioselective synthesis of R-(-)-tomoxetine,(R)-and(S)-fluoxetine [J].Tetrahedr Lett,1991,32(16):1901-1904.
|
[5] |
Ridvan L,Hruby P,Radl S,et al.A method for the preparation of(R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride(Atomoxetine):WO,2007009405[P].2007-01-25[2019-02-27] .
|
[6] |
Bai CM.Study on synthesis of duloxetine and atomoxetine(度洛西汀和托莫西汀的合成工艺研究)[D].Shanghai:East China Normal University,2011.
|
[7] |
Wu JQ,Zhou P,Liu Y,et al.An improved preparing process for rivastigmine [J].J China Pharm Univ(中国药科大学学报),2015,46(4):421-425.
|
[8] |
Liu HL,Hoff BH,Anthonsen T.Chemoenzymatic synthesis of the non-tricyclic antidepressants fluoxetine,tomoxetine and nisoxetine [J].J Chem Soc,Perkin Trans 1,2000,11:1767-1769.
|
[9] |
Vogl M, Kratzer R, Nidetzky B, et al. Candida tenuis xylose reductase catalyzed reduction of aryl ketones for enantioselective synthesis of active oxetine derivatives[J].Chirality,2012,24(10):847-853.
|
[10] |
Fu,BY,Zhang N,Duan CG,et al.A method for the chiral preparation of a key intermediate of dapoxetine hydrochloride(一种盐酸达泊西汀关键中间体的手性制备方法): CN,105732309 [P].2016-07-06[2019-02-27] .
|
[11] |
Chumpradit S, Kung MP, Panyachotipun C, et al. Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sites[J].J Med Chem, 1992,35(23):4492-4497.
|
[1] | LIU Li, LIU Zijin, TANG Jun, HE Guangwei, LIU Weizhong. Optimized synthesis process of tofacitinib citrate[J]. Journal of China Pharmaceutical University, 2022, 53(6): 685-689. DOI: 10.11665/j.issn.1000-5048.20220606 |
[2] | WU Xufeng, CHAI Shiying, LIU Jianhong, WANG Zhihui, YIN Ruifeng, CAO Ruiwei, SUN Xinqiang. Improvement of synthetic route of brivudine[J]. Journal of China Pharmaceutical University, 2022, 53(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20220106 |
[3] | HAN Chengqun, ZOU Qiaogen, SUN Qian, XIA Yunyan. Improvement of synthesis process of mirabegron[J]. Journal of China Pharmaceutical University, 2020, 51(4): 449-453. DOI: 10.11665/j.issn.1000-5048.20200409 |
[4] | MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106 |
[5] | WEI Qingjie, QIAO Junhua, CHEN Jianjun, GAO Zhigang, LI Yaqing. An improvement for synthesis of ceftriaxone sodium[J]. Journal of China Pharmaceutical University, 2016, 47(2): 163-165. DOI: 10.11665/j.issn.1000-5048.20160206 |
[6] | WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403 |
[7] | Technological Study of N-Chloro-Succimide Synthesis[J]. Journal of China Pharmaceutical University, 2001, (5): 78-79. |
[8] | Asymmetric Synthesis of6-Fluoro-L-DOPA[J]. Journal of China Pharmaceutical University, 2001, (3): 8-13. |
[9] | Asymmetric Reduction of Prochiral Ketones Using Chirally Modified Sodium Borohydride[J]. Journal of China Pharmaceutical University, 2000, (5): 7-9. |
[10] | The Synthesis of Ba m buterol[J]. Journal of China Pharmaceutical University, 1999, (4): 11-12. |